248
Views
2
CrossRef citations to date
0
Altmetric
Meta-analysis

Risk factors associated with mortality in hypersensitivity pneumonitis: a meta-analysis

, , , & ORCID Icon
Pages 801-811 | Received 22 Mar 2022, Accepted 07 Jul 2022, Published online: 25 Jul 2022

References

  • Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202(3):e36–69.
  • Terho E, Heinonen O, Lammi S, et al. Incidence of clinically confirmed farmer’s lung in Finland and its relation to meteorological factors. Eur J Respir Dis. 1987;152:47–56.
  • Thomeer M, Costabel U, Rizzato G, et al. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J. 2001;18(32):114s–8s.
  • Hyldgaard C, Hilberg O, Muller A, et al. A cohort study of interstitial lung diseases in central Denmark. Respir Med. 2014;108(5):793–799.
  • Singh S, Collins BF, Sharma BB, et al. Interstitial lung disease in India. Results of a prospective registry. Am J Respir Crit Care Med. 2017;195(6):801–813.
  • Arranz IO, Morell F, Villar A, et al. Mortality and survival predictor in chronic hypersensitivity pneumonitis. Eur Respir J. 2016;48:A833.
  • Bang KM, Weissman DN, Pinheiro GA, et al. Twenty‐three years of hypersensitivity pneumonitis mortality surveillance in the United States. Am J Ind Med. 2006;49(12):997–1004.
  • Fernández Pérez ER, Sprunger DB, Ratanawatkul P, et al. Increasing hypersensitivity pneumonitis–related mortality in the United States from 1988 to 2016. Am J Respir Crit Care Med. 2019;199(10):1284–1287.
  • Okamoto T, Miyazaki Y, Ogura T, et al. A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan. Respir Investig. 2013;51(3):191–199.
  • Wang L-J, Cai H-R, Xiao Y-L, et al. Clinical characteristics and outcomes of hypersensitivity pneumonitis: a population-based study in China. Chin Med J (Engl). 2019;132(11):1283–1292.
  • Mohamed NR, Ghazawy ER, Saeed ZH. Factors influencing the clinical presentation of hypersensitivity pneumonitis in pigeon breeders in Minia governorate: an Egyptian experience. Egypt J Bronchol. 2020;14(1):17.
  • Brown S-AW, Dobelle M, Padilla M, et al. Idiopathic pulmonary fibrosis and lung cancer. A systematic review and meta-analysis. Ann Am Thorac Soc. 2019;16(8):1041–1051.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;339:b2700.
  • Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
  • Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–129.
  • Viechtbauer W, Cheung MW-L. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112–125.
  • Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046–1055.
  • Adegunsoye A, Oldham JM, Demchuk C, et al. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016;114:53–60.
  • Adegunsoye A, Oldham JM, Bellam SK, et al. Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases. Ann Am Thorac Soc. 2019;16(5):580–588.
  • Choe J, Chae EJ, Kim YJ, et al. Serial changes of CT findings in patients with chronic hypersensitivity pneumonitis: imaging trajectories and predictors of fibrotic progression and acute exacerbation. Eur Radiol. 2021;31(6):3993–4003.
  • Chung JH, Zhan X, Cao M, et al. Presence of air trapping and mosaic attenuation on chest computed tomography predicts survival in chronic hypersensitivity pneumonitis. Ann Am Thorac Soc. 2017;14(10):1533–1538.
  • Chung JH, Montner SM, Adegunsoye A, et al. CT findings associated with survival in chronic hypersensitivity pneumonitis. Eur Radiol. 2017;27(12):5127–5135.
  • Pérez ERF, Swigris JJ, Forssén AV, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144(5):1644–1651.
  • Jacob J, Bartholmai BJ, Egashira R, et al. Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis. BMC Pulm Med. 2017;17(1):81.
  • Jacob J, Bartholmai B, Rajagopalan S, et al. Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis. Eur Radiol. 2017;27(9):3635–3646.
  • Jacob J, Odink A, Brun AL, et al. Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis. Respir Med. 2018;138:95–101.
  • Lima MS, Coletta ENAM, Ferreira RG, et al. Subacute and chronic hypersensitivity pneumonitis: histopathological patterns and survival. Respir Med. 2009;103(4):508–515.
  • Long X, He X, Ohshimo S, et al. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis. Eur Respir J. 2017;49(2):1501924.
  • Mooney JJ, Elicker BM, Urbania TH, et al. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest. 2013;144(2):586–592.
  • Nukui Y, Miyazaki Y, Masuo M, et al. Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis. Allergol Int. 2019;68(3):363–369.
  • Ojanguren I, Morell F, Ramón M-A, et al. Long-term outcomes in chronic hypersensitivity pneumonitis. Allergy. 2019;74(5):944–952.
  • Rittig AH, Hilberg O, Ibsen R, et al. Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study. ERJ Open Res. 2019;52:A3659.
  • Salisbury ML, Gu T, Murray S, et al. Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory. Chest. 2019;155(4):699–711.
  • Tateishi T, Ohtani Y, Takemura T, et al. Serial high-resolution computed tomography findings of acute and chronic hypersensitivity pneumonitis induced by avian antigen. J Comput Assist Tomogr. 2011;35(2):272–279.
  • Tsutsui T, Miyazaki Y, Kuramochi J, et al. The amount of avian antigen in household dust predicts the prognosis of chronic bird-related hypersensitivity pneumonitis. Ann Am Thorac Soc. 2015;12(7):1013–1021.
  • Walsh SLF, Sverzellati N, Devaraj A, et al. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur Radiol. 2012;22(8):1672–1679.
  • Wang P, Jones KD, Urisman A, et al. Pathologic findings and prognosis in a large prospective cohort of chronic hypersensitivity pneumonitis. Chest. 2017;152(3):502–509.
  • Hanzawa S, Tateishi T, Ishizuka M, et al. Changes in serum KL-6 levels during short-term strict antigen avoidance are associated with the prognosis of patients with fibrotic hypersensitivity pneumonitis caused by avian antigens. Respir Investig. 2020;58(6):457–464.
  • Meyer K. Interstitial lung disease in the elderly: pathogenesis, diagnosis and management. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28(1):3–17.
  • Leuschner G, Klotsche J, Kreuter M, et al. Idiopathic pulmonary fibrosis in elderly patients: analysis of the INSIGHTS-IPF observational study. Front Med (Lausanne). 2020;7:601279.
  • Dawod YT, Cook NE, Graham WB, et al. Smoking-associated interstitial lung disease: update and review. Expert Rev Respir Med. 2020;14(8):825–834.
  • Blanchet M, Israel-Assayag E, Cormier Y. Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist. Eur Respir J. 2005;26(1):21–27.
  • Cormier Y, Israël-Assayag E, Bédard G, et al. Hypersensitivity pneumonitis in peat moss processing plant workers. Am J Respir Crit Care Med. 1998;158(2):412–417.
  • Udwadia ZF, Pokhariyal PK, Tripathi AK, et al. Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids. Lung India. 2021;38(Suppl 1):S61–3.
  • Engeler CE, Tashjian JH, Trenkner SW, et al. Ground-glass opacity of the lung parenchyma: a guide to analysis with high-resolution CT. Am J Roentgenol. 1993;60(2):249–251.
  • Hanley A, Hubbard R, Navaratnam V. Mortality trends in asbestosis, extrinsic allergic alveolitis and sarcoidosis in England and Wales. Respir Med. 2011;105(9):1373–1379.
  • Clarson LE, Bajpai R, Whittle R, et al. Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction. Heart. 2020;106(12):916–922.
  • Marshall DC, Salciccioli JD, Shea BS, et al. Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013. Eur Respir J. 2018;51(1):1701603.
  • Sema M, Miyazaki Y, Tsutsui T, et al. Environmental levels of avian antigen are relevant to the progression of chronic hypersensitivity pneumonitis during antigen avoidance. Immun Inflamm Dis. 2018;6(1):154–162.
  • Hanak V, Golbin JM, Hartman TE, et al. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest. 2008;134(1):133–138.
  • Sahin H, Brown KK, Curran-Everett D, et al. Chronic hypersensitivity pneumonitis: CT features—comparison with pathologic evidence of fibrosis and survival. Radiology. 2007;244(2):591–598.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.